Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1998-08-13
1999-12-28
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
A61K 3166
Patent
active
060082070
ABSTRACT:
Disclosed is a method for treating and preventing bone loss in patients by administering a formulation of anhydrous alendronate sodium. Also described is a pharmaceutical doage form of said anhydrous alendronate sodium, being anhydrous 4-amino-1-hydroxy-butylidene-1,1-bisphosphonic acid, monosodium salt, in a pharmaceutically acceptable excipient.
REFERENCES:
patent: 4621077 (1986-11-01), Rosini et al.
patent: 4922007 (1990-05-01), Kieczykowski et al.
patent: 5019651 (1991-05-01), Keiczykowski
patent: 5849726 (1998-12-01), Brenner et al.
Brenner Gerald S.
Oberholtzer, Jr. Earl R.
Ostovic Drazen
Thies J. Eric
Henley III Raymond
Merck & Co. , Inc.
Sabatelli Anthony D.
Winokur Melvin
LandOfFree
Anhydrous alendronate monosodium salt formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anhydrous alendronate monosodium salt formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anhydrous alendronate monosodium salt formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2382518